Dextromethorphan, or DXM, is the cough suppressant in over 100 over-the-counter cold medicines, safe at label doses but capable of producing dissociative effects similar to ketamine or PCP at 10 to 50 times that amount. It’s often framed as a teenage problem, but chronic DXM dependence in adults is documented too, and the drug carries specific risks, including dangerous interactions with common antidepressants, that go beyond the dissociative high itself. This guide covers how DXM abuse actually works, its distinct risks, and what treatment involves.
Dextromethorphan (DXM) is an over-the-counter cough suppressant that produces dissociative effects similar to ketamine or PCP when taken at 10 to 50 times the recommended dose. Effects scale through four dose-dependent stages users call plateaus, from mild stimulation around 100 to 200mg to profound dissociation above 600mg. DXM doesn’t appear on standard drug tests, interacts dangerously with common antidepressants that inhibit its metabolism, and can cause chronic dependence in both teenagers and adults.
What Is DXM Abuse?
DXM abuse means taking dextromethorphan, the active ingredient in cough medicines like Robitussin and Coricidin, at doses far beyond the label recommendation to produce a dissociative high. At normal doses, typically 10 to 30mg, it safely suppresses coughs. At recreational doses, commonly 100mg and up, it blocks NMDA receptors in a way that produces dissociation, hallucinations, and an altered sense of reality, with effects broadly similar to ketamine or PCP at comparable intensity.
DXM has been safely used in cough medicine since the 1950s, and its abuse follows a well-documented, cyclical pattern going back nearly as long: periods of rising misuse, media attention, product reformulation attempts, and then a resurgence once the pattern fades from public awareness. That history matters practically, since it means DXM abuse isn’t a novel trend that will simply disappear; it recurs in waves tied to how much attention it’s currently getting, not to any lasting change in how accessible or risky it is.
The Plateaus: How DXM Effects Scale With Dose
Users and clinicians both describe DXM’s effects using a four-stage dose scale often called plateaus, a scale the DEA has also used to document the drug’s risk profile.
Plateau 1, roughly 100 to 200mg, produces mild stimulation, euphoria, and distorted visual perception, an effect some compare to light alcohol intoxication. Plateau 2, around 200 to 400mg, intensifies this into more pronounced perceptual changes and impaired coordination. Plateau 3, roughly 400 to 600mg, brings full hallucinations and a meaningful dissociation from physical reality. Plateau 4, doses above 600mg, produces profound dissociation, extreme sedation, and a significant risk of loss of consciousness.
Each plateau requires a proportionally higher dose than the last, and the escalation logic, that more DXM produces a categorically different and more intense experience, is often learned during a person’s very first recreational use. This dose-response relationship is part of why DXM abuse tends to escalate over repeated use rather than settling at a stable, lower-risk dose.
Pharmacologically, DXM and its metabolite dextrorphan work primarily by blocking NMDA receptors, the same receptor system targeted by ketamine and PCP, which explains the similarity in subjective effects across these otherwise unrelated drugs. At higher doses, DXM also inhibits catecholamine reuptake and acts on serotonin receptors, which is part of why its effects aren’t purely dissociative; users commonly report adrenergic symptoms like elevated heart rate and sweating alongside the perceptual changes, a combination that doesn’t show up with a cleaner dissociative like ketamine alone.
Recognizing which plateau someone may have reached matters practically for anyone responding to a suspected episode. Mild stimulation and euphoria at Plateau 1 rarely require emergency intervention on their own. Full dissociation, extreme sedation, or loss of consciousness at Plateau 3 or 4 are medical emergencies, and treating them as anything less risks missing a genuinely dangerous presentation.
Not Just a Teen Issue: Chronic DXM Dependence in Adults
DXM abuse is often framed as an adolescent problem, and the demographics do skew young: national poison control data consistently shows teenagers and young adults account for the majority of DXM-related emergency presentations. If you’re specifically looking for how to recognise DXM use in a teenager, this guide for parents covers the behavioral signs and what to do next in more detail. But chronic dependence in adults is real and documented, if underrecognized.
A published case report described a 66-year-old office worker who regularly consumed 4 to 16 ounces of DXM-containing cough syrup over an eight-year period, a pattern the researchers noted is rarely captured in primary care literature despite a meaningful body of specialty case reports. The researchers specifically flagged how easily this kind of chronic use goes undetected: it doesn’t fit the profile clinicians are trained to watch for, and standard screening doesn’t catch it.
The underlying mechanism, legal access, low cost, and a substance that doesn’t show up on standard drug tests, applies just as much to a 45-year-old as a 15-year-old. Age isn’t a reliable filter for who’s at risk; access and pattern of use are the more relevant factors.
What makes adult cases particularly hard to catch is how ordinary they look from the outside. A working adult who regularly buys cough syrup doesn’t raise the same flags a teenager repeatedly emptying the family medicine cabinet does. There’s no unusual purchasing pattern for a pharmacist to notice, no obvious behavioral change tied to a household supply running out, and no parent tracking the count. The same features that make DXM easy for a teenager to hide, legality, low cost, no prescription, make an adult’s chronic use functionally invisible to everyone around them, including, in many cases, their own physician.
Dangerous Drug Interactions
DXM’s risks extend well beyond the dissociative effects it’s typically abused for, and several of the more serious ones involve interactions most people wouldn’t expect.
Medications that inhibit the CYP2D6 liver enzyme, including common antidepressants such as bupropion, fluoxetine, and paroxetine, slow DXM’s metabolism and can raise plasma concentrations significantly. This means someone taking one of these medications can experience toxicity at a DXM dose they previously tolerated without issue, since their body is no longer clearing the drug at the expected rate.
Combining DXM with SSRIs or other serotonergic medications also raises the risk of serotonin syndrome, a potentially serious reaction involving high fever, rapid heart rate, and muscle rigidity that can require emergency treatment. DXM and alcohol together produce a distinct danger of their own: the combination can cause dissociative symptoms severe enough to be mistaken for alcohol withdrawal, complicating diagnosis in someone who also drinks.
Clinically, DXM-induced psychosis has a specific treatment wrinkle worth noting: haloperidol, a medication sometimes used for drug-induced psychosis generally, is specifically flagged in case literature as one to avoid in DXM-related presentations, since it can interact poorly with DXM’s pharmacological profile. This is a detail relevant to emergency treatment, not something to self-manage, but it illustrates how DXM’s risks don’t follow the same pattern as more commonly recognized drugs of abuse.
There’s also a less obvious risk worth knowing about: forensic laboratories have documented DXM being used as a bulking agent mixed into street heroin samples, added to increase volume while also intensifying the heroin’s effects through pharmacological interaction between the two substances. Someone using heroin from an unknown source has no reliable way to know whether DXM is part of what they’re taking, which adds an additional layer of unpredictable interaction risk on top of whatever else that heroin might be cut with.
Does DXM Show Up on a Drug Test? And Urinary Retention
Standard drug tests, including home urine panels and most basic panels ordered by a general practitioner, do not screen for dextromethorphan. A clean result doesn’t rule out DXM use; it means DXM specifically wasn’t part of what was tested. Testing for it requires requesting a panel that includes dextromethorphan by name.
Urinary retention is a documented, less commonly discussed effect associated with dextromethorphan, more often reported at higher or combination-product doses rather than standard therapeutic use. It relates to DXM’s broader pharmacological profile rather than being unique to abuse specifically, and anyone experiencing difficulty urinating after taking a DXM-containing product, at any dose, should raise it with a doctor or pharmacist rather than assuming it will resolve on its own.
Withdrawal and Treatment
DXM withdrawal isn’t as extensively documented as withdrawal from substances like alcohol or opioids, but regular users report genuine psychological symptoms on cessation: cravings, irritability, restlessness, and anxiety, consistent with a real dependence pattern rather than simple habit.
Because DXM is often combined with other active ingredients, acetaminophen, antihistamines, or decongestants, in the products actually being abused, treatment needs to account for potential organ damage from those components, not just the DXM component itself. Regular high-dose use, particularly of acetaminophen-containing products, carries a real risk of cumulative liver damage that can progress with minimal early symptoms.
Medical evaluation at the start of treatment, including assessment of what specific products and doses were involved, helps identify risks beyond the dissociative effects that brought someone to treatment in the first place.
Because DXM interacts with a range of common medications and doesn’t reliably show up on standard testing, an accurate medication and use history matters more here than with many other substances. Treatment that starts without knowing whether someone is also taking a CYP2D6-inhibiting antidepressant, or whether their DXM use has been combined with alcohol, is working with an incomplete picture of the actual risk involved.
Frequently Asked Questions
Can You Get Addicted to DXM?
Yes. Regular users report tolerance, needing progressively higher doses for the same effect, and cravings or anxiety when the drug isn’t available. This pattern meets the functional definition of addiction regardless of DXM’s legal, over-the-counter status.
Does DXM Interact With Antidepressants?
Yes, and the interaction can be dangerous. Antidepressants that inhibit the CYP2D6 enzyme, including bupropion, fluoxetine, and paroxetine, slow DXM’s metabolism and can cause toxicity at doses previously tolerated without issue. Combination with SSRIs also raises the risk of serotonin syndrome.
Is DXM Abuse Only a Concern for Teenagers?
No. While teenagers and young adults account for the majority of DXM-related emergency presentations, documented cases of chronic DXM dependence in adults exist and are likely underrecognized, since the pattern doesn’t fit what clinicians are typically trained to screen for.
Can DXM Be Mixed Into Other Drugs Without Someone Knowing?
Yes. Forensic labs have found DXM used as a bulking agent in street heroin, added to increase volume and intensify effects. Anyone using heroin or other illicit drugs from an unregulated source has no reliable way to know whether DXM, or other adulterants, are present.
What’s the Difference Between DXM Withdrawal and a Bad Trip?
A bad trip refers to acute distress during intoxication, while withdrawal describes symptoms that appear after stopping regular use, cravings, irritability, restlessness, and anxiety in DXM’s case. Someone can experience either independently, though heavy, prolonged use raises the likelihood of both.
Struggling With DXM or Cough Medicine Abuse?
Siam Rehab’s medical team can talk through what assessment and treatment for DXM dependence involves.
